Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
4.050
-0.200 (-4.71%)
At close: Apr 28, 2026, 4:00 PM EDT
4.070
+0.020 (0.49%)
After-hours: Apr 28, 2026, 6:44 PM EDT

Zentalis Pharmaceuticals Statistics

Total Valuation

ZNTL has a market cap or net worth of $287.27 million. The enterprise value is $87.34 million.

Market Cap 287.27M
Enterprise Value 87.34M

Important Dates

The next estimated earnings date is Thursday, May 7, 2026, before market open.

Earnings Date May 7, 2026
Ex-Dividend Date n/a

Share Statistics

ZNTL has 70.93 million shares outstanding. The number of shares has increased by 1.11% in one year.

Current Share Class 70.93M
Shares Outstanding 70.93M
Shares Change (YoY) +1.11%
Shares Change (QoQ) -0.66%
Owned by Insiders (%) 1.59%
Owned by Institutions (%) 53.28%
Float 48.67M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.36
P/TBV Ratio 1.36
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.93, with a Debt / Equity ratio of 0.18.

Current Ratio 6.93
Quick Ratio 6.73
Debt / Equity 0.18
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -49.53% and return on invested capital (ROIC) is -27.70%.

Return on Equity (ROE) -49.53%
Return on Assets (ROA) -24.48%
Return on Invested Capital (ROIC) -27.70%
Return on Capital Employed (ROCE) -55.81%
Weighted Average Cost of Capital (WACC) 11.79%
Revenue Per Employee n/a
Profits Per Employee -$1.29M
Employee Count 106
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, ZNTL has paid $442,000 in taxes.

Income Tax 442,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +183.22% in the last 52 weeks. The beta is 1.66, so ZNTL's price volatility has been higher than the market average.

Beta (5Y) 1.66
52-Week Price Change +183.22%
50-Day Moving Average 3.12
200-Day Moving Average 2.07
Relative Strength Index (RSI) 53.25
Average Volume (20 Days) 4,543,293

Short Selling Information

The latest short interest is 5.20 million, so 7.34% of the outstanding shares have been sold short.

Short Interest 5.20M
Short Previous Month 4.26M
Short % of Shares Out 7.34%
Short % of Float 10.69%
Short Ratio (days to cover) 1.39

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -140.88M
Pretax Income -136.62M
Net Income -137.06M
EBITDA -140.14M
EBIT -140.88M
Earnings Per Share (EPS) -$1.91
Full Income Statement

Balance Sheet

The company has $245.89 million in cash and $39.58 million in debt, giving a net cash position of $206.32 million or $2.91 per share.

Cash & Cash Equivalents 245.89M
Total Debt 39.58M
Net Cash 206.32M
Net Cash Per Share $2.91
Equity (Book Value) 216.20M
Book Value Per Share 3.13
Working Capital 216.63M
Full Balance Sheet

Cash Flow

Operating Cash Flow -125.25M
Capital Expenditures n/a
Depreciation & Amortization 739,000
Net Borrowing n/a
Free Cash Flow -125.25M
FCF Per Share -$1.77
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ZNTL does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.11%
Shareholder Yield -1.11%
Earnings Yield -46.67%
FCF Yield -42.65%

Analyst Forecast

The average price target for ZNTL is $6.60, which is 62.96% higher than the current price. The consensus rating is "Buy".

Price Target $6.60
Price Target Difference 62.96%
Analyst Consensus Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1